Eric Katagirya
Overview
Explore the profile of Eric Katagirya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Adzemovic T, Kabbale K, Katagirya E, Mukisa J, Wayengera M
Genet Med Open
. 2024 Dec;
2(Suppl 2):101879.
PMID: 39712973
No abstract available.
2.
Mukisa J, Kyobe S, Amujal M, Katagirya E, Diphoko T, Sebetso G, et al.
bioRxiv
. 2024 Dec;
PMID: 39677597
Killer-cell immunoglobulin-like receptors (s) are essential components of the innate immune system found on the surfaces of natural killer (NK) cells. The s encoding genes are located on chromosome 19q13.4...
3.
Maghembe R, Magulye M, Makaranga A, Nsubuga G, Sekyanzi S, Moto E, et al.
Heliyon
. 2024 Nov;
10(20):e39455.
PMID: 39498086
Pediatric meningitis is a global health problem, with insufficiently known pathogens and antibiotic resistance (AMR) especially in low-resource settings. Here, we sought to uncover the virulence and AMR of pathogens...
4.
Atugonza C, Muwonge A, Najjuka C, Kateete D, Katagirya E, Mwesigwa S, et al.
medRxiv
. 2024 Oct;
PMID: 39417122
Daily cotrimoxazole (TMP/SXT) prophylaxis is part of the HIV treatment package for all new HIV-infected individuals in Uganda. Although this treatment has shown reduced morbidity and mortality in HIV, it...
5.
Kyobe S, Mwesigwa S, Nkurunungi G, Retshabile G, Egesa M, Katagirya E, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273630
Efforts towards an effective HIV-1 vaccine have remained mainly unsuccessful. There is increasing evidence for a potential role of HLA-C-restricted CD8 T cell responses in HIV-1 control, including our recent...
6.
Maghembe R, Magulye M, Makaranga A, Moto E, Sekyanzi S, Mwesigwa S, et al.
Infect Genet Evol
. 2024 Jul;
123:105640.
PMID: 39002874
The Klebsiella oxytoca complex comprises diverse opportunistic bacterial pathogens associated with hospital and community-acquired infections with growing alarming antimicrobial resistance. We aimed to uncover the genomic features underlying the virulence...
7.
Maghembe R, Magulye M, Eilu E, Sekyanzi S, Mwesigwa S, Katagirya E
Heliyon
. 2024 May;
10(9):e30187.
PMID: 38707307
Sepsis and drug resistance represent a complex of the most common global causes of mortality in intensive care units (ICUs) especially among patients with comorbidities. Extraintestinal pathogenic (ExPEC) strains are...
8.
Maghembe R, Magulye M, Eilu E, Sekyanzi S, Makaranga A, Mwesigwa S, et al.
Infect Genet Evol
. 2024 Apr;
120:105591.
PMID: 38604286
Sepsis and multidrug resistance comprise a complex of factors attributable to mortality among intensive care unit (ICU) patients globally. Pathogens implicated in sepsis are diverse, and their virulence and drug...
9.
Kyobe S, Kisitu G, Mwesigwa S, Farirai J, Katagirya E, Retshabile G, et al.
Int J Infect Dis
. 2023 Nov;
139:132-140.
PMID: 38036259
Objectives: We utilize a large retrospective study cohort derived from electronic medical records to estimate the prevalence of long-term non-progression (LTNP) and determine the factors associated with progression among children...
10.
Kia P, Katagirya E, Kakembo F, Adera D, Nsubuga M, Yiga F, et al.
Sci Rep
. 2023 Nov;
13(1):20507.
PMID: 37993530
SARS-CoV-2 undergoes frequent mutations, affecting COVID-19 diagnostics, transmission and vaccine efficacy. Here, we describe the genetic diversity of 49 SARS-CoV-2 samples from Uganda, collected during the COVID-19 waves of 2020/2021....